Biovie Inc Stock Performance
as on October 23, 2025 at 1:29 am IST
Day's Low
Day's High
$1.83$1.91
2.66%
Downside
1.60%
Upside
52 Week's Low
52 Week's High
$1.42$44.824.47%
Downside
2282.98%
Upside
Biovie Inc share price movements today
- Previous Close
- $1.91
- Open
- $1.91
- Volume
- 457.5K
- Day's Low - High
- $1.83 - $1.91
- 52 Week Low - High
- $1.42 - $44.8
Biovie Inc Historical Returns
- 1 Month Return
- + 1.63 %
- 3 Month Return
- -77.31 %
- 1 Year Return
- -92.72 %
- 3 Year Return
- -99.45 %
- 5 Year Return
- -99.79 %
Biovie Inc Stock Fundamentals & Key Indicators
Check Biovie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.4M
EPS (TTM)
-11.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-17.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-101.64%
Biovie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biovie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $14.4M | -99.79% | NA | 0.00% | ||
| BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
| BUY | $61.3B | 0.85% | 14.6 | 31.37% |
Stock Returns calculator for Biovie Inc Stock including INR - Dollar returns
The Biovie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biovie Inc investment value today
Current value as on today
₹11,968
Returns
Returns from Biovie Inc Stock
Dollar Returns*
₹4,653 (+4.65%)
Analyst Recommendation on Biovie Inc Stock
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Biovie Inc. Average target price of $12
Biovie Inc Share Price Target
Get share price movements and forecasts by analysts on Biovie Inc.
What analysts predicted
84.33%UPSIDE
Target Price
$12
Current Price
$1.88
Analyzed by
6 Analysts
Target
$12.00
Biovie Inc target price $12, a slight upside of 84.33% compared to current price of $1.88. According to 6 analysts rating.
Biovie Inc Stock’s Investor Sentiment and Interest
Search interest for Biovie Inc Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Biovie Inc Quarterly Profit & Loss
All numbers in Millions USD
Biovie Inc Annual Profit & Loss
All numbers in Millions USD
Biovie Inc Quarterly Cash Flow
All numbers in Millions USD
Biovie Inc Annual Cash Flow
All numbers in Millions USD
Insights on Biovie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 150.4%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 233.3%
NEGATIVE IMPACTPrice Dip
In the last 3 months, BIVI stock has moved down by -77.3%
About Biovie Inc
| Organisation | Biovie Inc |
| Headquarters | 680 W. Nye Lane, Carson City, NV, United States, 89703 |
| Industry | Biotechnology |
| CEO | Mr. Cuong Viet Do M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Biovie Inc
Name | Title |
|---|---|
Mr. David Morse | Senior VP & Chief Regulatory Officer |
Mr. Cuong Viet Do M.B.A. | President, CEO & Director |
Ms. Joanne Wendy Kim CPA | CFO, Treasurer & Corporate Secretary |
Dr. Joseph M. Palumbo M.D. | Executive VP of R&D and Chief Medical Officer |
Mr. Clarence N. Ahlem | Senior Vice President of Operations |
Dr. Penelope Markham Ph.D. | Senior Vice President of Liver Disease Program |
Ms. Denise Smith | Senior Vice President of Manufacturing & Development |
Dr. Christopher L. Reading Ph.D. | Senior Vice President of Alzheimer's Disease Program |
FAQs
What is Biovie Inc share price today?
Biovie Inc share price today is $1.88 as on at the close of the market. Biovie Inc share today touched a day high of $1.91 and a low of $1.83.
What is the 52 week high and 52 week low for Biovie Inc share?
Biovie Inc share touched a 52 week high of $44.8 on and a 52 week low of $1.42 on . Biovie Inc stock price today i.e. is closed at $1.88,which is 95.80% down from its 52 week high and 32.39% up from its 52 week low.
What is Biovie Inc's market capitalisation today?
Biovie Inc market capitalisation is $0.00T as on .
How to invest in Biovie Inc Stock (BIVI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Biovie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Inc Shares that will get you 0.7979 shares as per Biovie Inc share price of $1.88 per share as on October 23, 2025 at 1:29 am IST.
What is the minimum amount required to buy Biovie Inc Stock (BIVI) from India?
Indian investors can start investing in Biovie Inc (BIVI) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Biovie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biovie Inc share’s latest price of $1.88 as on October 23, 2025 at 1:29 am IST, you will get 5.3191 shares of Biovie Inc. Learn more about
fractional shares .
What are the returns that Biovie Inc has given to Indian investors in the last 5 years?
Biovie Inc stock has given -99.79% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?